Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages.

Gut · 2015 · PMC4520782 · PMID 25636698

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

It should be noted while that our analysis calculated an average time to progression through different TNM stages, there is likely to be significant heterogeneity in the rate of progression of pancreatic cancers in individual patients.

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.